532330 — Biopac India Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -360.17% | ||
Financial Summary
| Year End 31st Mar | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 520.97 | 477.72 | 472.1 | 202.44 | 49.1 | n/a | n/a | -39.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -94.07 | +89.56 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biopac India Corporation Limited is an India-based company. The Company manufactures foam disposable food service products and food storage containers. The Company’s main business is food service disposables and food storage and packaging. The Company has more than 150 manufacturing units and focuses on new product development and application.
Directors
- Harish Doshi CHM (63)
- Pankaj Doshi CCO (61)
- Smita Sanghavi IND (59)
- Hemant Bhuta NID
- R. Maker NID (64)
- Mehul Patel NID
- Last Annual
- March 31st, 2020
- Last Interim
- September 30th, 2020
- Incorporated
- April 2nd, 1987
- Public Since
- April 18th, 2000
- Sector
- Containers & Packaging
- Industry
- Basic Materials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 17,250,100
- Address
- 301/302, MUMBAI, 400053
- Web
- http://www.biopacindia.com/
- Phone
- +91 2266950317
- Contact
- Pankaj Doshi
- Auditors
- APMH & Associates LLP
Upcoming Events for 532330
Similar to 532330
Aadi Industries
Bombay Stock Exchange
Adarsh Plant Protect
Bombay Stock Exchange
Anuroop Packaging
Bombay Stock Exchange
Balmer Lawrie Investments
Bombay Stock Exchange
B & A Packaging India
Bombay Stock Exchange
FAQ
As of Today at 19:03 UTC, shares in Biopac India are trading at IN₹1.99. This share price information is delayed by 15 minutes.
Shares in Biopac India last closed at IN₹1.99 and the price had moved by +21.34% over the past 365 days. In terms of relative price strength the Biopac India share price has underperformed the S&P BSE 100 Index by -8.04% over the past year.
There is no consensus recommendation for this security.
Biopac India does not currently pay a dividend.
Biopac India does not currently pay a dividend.
Biopac India does not currently pay a dividend.
To buy shares in Biopac India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1.99, shares in Biopac India had a market capitalisation of .
Here are the trading details for Biopac India:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 532330
Based on an overall assessment of its quality, value and momentum Biopac India is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biopac India. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -24.26%.
As of the last closing price of IN₹1.99, shares in Biopac India were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biopac India PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biopac India's management team is headed by:
- Harish Doshi - CHM
- Pankaj Doshi - CCO
- Smita Sanghavi - IND
- Hemant Bhuta - NID
- R. Maker - NID
- Mehul Patel - NID